[{"id":"03cc6bc8-5618-4603-9100-4c0895d92154","acronym":"","url":"https://clinicaltrials.gov/study/NCT00295919","created_at":"2021-01-18T01:00:35.845Z","updated_at":"2024-07-02T16:35:51.193Z","phase":"Phase 1","brief_title":"N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma","source_id_and_acronym":"NCT00295919","lead_sponsor":"Children's Hospital Los Angeles","biomarkers":" ABCB1","pipe":"","alterations":" ","tags":["ABCB1"],"overall_status":"Completed","enrollment":" Enrollment 80","initiation":"Initiation: 12/01/2005","start_date":" 12/01/2005","primary_txt":" Primary completion: 03/01/2014","primary_completion_date":" 03/01/2014","study_txt":" Completion: 05/01/2015","study_completion_date":" 05/01/2015","last_update_posted":"2023-04-07"},{"id":"ed788d65-0132-4f88-b51e-b0cbc192fc90","acronym":"","url":"https://clinicaltrials.gov/study/NCT05638763","created_at":"2022-12-06T15:57:59.939Z","updated_at":"2024-07-02T16:35:59.603Z","phase":"Phase 2","brief_title":"Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia","source_id_and_acronym":"NCT05638763","lead_sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","biomarkers":" ABL1","pipe":"","alterations":" ","tags":["ABL1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 11/01/2024","start_date":" 11/01/2024","primary_txt":" Primary completion: 11/01/2024","primary_completion_date":" 11/01/2024","study_txt":" Completion: 11/01/2024","study_completion_date":" 11/01/2024","last_update_posted":"2022-12-06"},{"id":"c865fa8d-eedd-4411-807c-9590facd411f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05591560","created_at":"2022-10-24T13:56:57.884Z","updated_at":"2024-07-02T16:36:01.977Z","phase":"","brief_title":"Itraconazole in Advanced Ovarian Cancer","source_id_and_acronym":"NCT05591560","lead_sponsor":"Tanta University","biomarkers":" KDR • MUC16","pipe":"","alterations":" ","tags":["KDR • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • itraconazole"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 66","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 10/01/2024","study_completion_date":" 10/01/2024","last_update_posted":"2022-10-24"},{"id":"ae1e8c24-b294-4351-8115-ef1d4ef0a78a","acronym":"","url":"https://clinicaltrials.gov/study/NCT04018872","created_at":"2021-11-04T14:52:58.385Z","updated_at":"2024-07-02T16:36:21.182Z","phase":"Phase 2","brief_title":"Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer","source_id_and_acronym":"NCT04018872","lead_sponsor":"Dallas VA Medical Center","biomarkers":" KDR • GLI1 • GLI3 • GLI2 • SHH","pipe":" | ","alterations":" GLI3 expression","tags":["KDR • GLI1 • GLI3 • GLI2 • SHH"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GLI3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e itraconazole"],"overall_status":"Recruiting","enrollment":" Enrollment 78","initiation":"Initiation: 06/24/2019","start_date":" 06/24/2019","primary_txt":" Primary completion: 06/24/2026","primary_completion_date":" 06/24/2026","study_txt":" Completion: 09/29/2026","study_completion_date":" 09/29/2026","last_update_posted":"2021-11-04"},{"id":"07ab0b3d-bc1a-42e9-9660-c94404b073c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT00000992","created_at":"2021-01-29T06:52:48.885Z","updated_at":"2024-07-02T16:36:21.790Z","phase":"Phase 1","brief_title":"A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS","source_id_and_acronym":"NCT00000992","lead_sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e itraconazole"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":" Completion: 06/01/1992","study_completion_date":" 06/01/1992","last_update_posted":"2021-11-01"},{"id":"859d4daf-1a31-438b-8dbf-f8ed4a89b5e1","acronym":"","url":"https://clinicaltrials.gov/study/NCT02357836","created_at":"2021-05-03T19:53:14.312Z","updated_at":"2024-07-02T16:36:30.803Z","phase":"Phase 1","brief_title":"Neoadjuvant Itraconazole in Non-small Cell Lung Cancer","source_id_and_acronym":"NCT02357836","lead_sponsor":"University of Texas Southwestern Medical Center","biomarkers":" CCND1 • PTCH1 • HIF1A • CD34 • GLI1 • CASP3 • CD31 • GLI2 • PECAM1","pipe":" | ","alterations":" MTOR mutation","tags":["CCND1 • PTCH1 • HIF1A • CD34 • GLI1 • CASP3 • CD31 • GLI2 • PECAM1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MTOR mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e itraconazole"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 06/01/2015","start_date":" 06/01/2015","primary_txt":" Primary completion: 07/01/2018","primary_completion_date":" 07/01/2018","study_txt":" Completion: 07/01/2018","study_completion_date":" 07/01/2018","last_update_posted":"2021-05-03"},{"id":"6ffd26d0-764c-4b8b-a3bb-a291e30726d2","acronym":"ZENITH","url":"https://clinicaltrials.gov/study/NCT03159845","created_at":"2021-01-18T15:34:43.301Z","updated_at":"2024-07-02T16:36:51.816Z","phase":"Phase 2","brief_title":"Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies","source_id_and_acronym":"NCT03159845 - ZENITH","lead_sponsor":"Azienda Ospedaliero, Universitaria Pisana","biomarkers":" CD8 • CD28 • CD27","pipe":"","alterations":" ","tags":["CD8 • CD28 • CD27"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 01/01/2014","start_date":" 01/01/2014","primary_txt":" Primary completion: 09/10/2019","primary_completion_date":" 09/10/2019","study_txt":" Completion: 09/10/2019","study_completion_date":" 09/10/2019","last_update_posted":"2020-01-07"},{"id":"eebab600-0270-4c73-93ad-9585470f5fa2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02735356","created_at":"2021-01-18T13:23:41.790Z","updated_at":"2024-07-02T16:37:00.682Z","phase":"Phase 1","brief_title":"Topical Itraconazole in Treating Patients With Basal Cell Cancer","source_id_and_acronym":"NCT02735356","lead_sponsor":"Jean Yuh Tang","biomarkers":" GLI1","pipe":"","alterations":" ","tags":["GLI1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e itraconazole • Tolsura (SUBA-itraconazole)"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 05/05/2016","start_date":" 05/05/2016","primary_txt":" Primary completion: 09/19/2017","primary_completion_date":" 09/19/2017","study_txt":" Completion: 10/10/2017","study_completion_date":" 10/10/2017","last_update_posted":"2019-04-11"},{"id":"cb37c59b-60aa-448c-a3c1-3a12036668ac","acronym":"","url":"https://clinicaltrials.gov/study/NCT01108094","created_at":"2021-01-18T04:23:15.095Z","updated_at":"2024-07-02T16:37:05.394Z","phase":"Phase 2","brief_title":"Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas","source_id_and_acronym":"NCT01108094","lead_sponsor":"Stanford University","biomarkers":" GLI1","pipe":"","alterations":" ","tags":["GLI1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e itraconazole"],"overall_status":"Completed","enrollment":" Enrollment 29","initiation":"Initiation: 04/01/2010","start_date":" 04/01/2010","primary_txt":" Primary completion: 03/01/2011","primary_completion_date":" 03/01/2011","study_txt":" Completion: 02/01/2012","study_completion_date":" 02/01/2012","last_update_posted":"2018-11-13"},{"id":"63a32025-a378-41c2-83ba-bd2b85330c99","acronym":"","url":"https://clinicaltrials.gov/study/NCT03267407","created_at":"2021-01-29T07:15:23.069Z","updated_at":"2024-07-02T16:37:18.023Z","phase":"","brief_title":"Vietnam Cryptococcal Retention in Care Study - Version 2.1","source_id_and_acronym":"NCT03267407","lead_sponsor":"National Hospital for Tropical Diseases, Hanoi, Vietnam","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"],"overall_status":"Unknown status","enrollment":" Enrollment 1184","initiation":"Initiation: 08/14/2015","start_date":" 08/14/2015","primary_txt":" Primary completion: 03/31/2018","primary_completion_date":" 03/31/2018","study_txt":" Completion: 03/31/2018","study_completion_date":" 03/31/2018","last_update_posted":"2017-09-12"},{"id":"d07fe802-801f-4f3e-98cb-ea36f93c4dad","acronym":"","url":"https://clinicaltrials.gov/study/NCT01550692","created_at":"2021-01-18T06:33:42.703Z","updated_at":"2024-07-02T16:37:19.351Z","phase":"Phase 1/2","brief_title":"Trial of Fenretinide/LXS Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma","source_id_and_acronym":"NCT01550692","lead_sponsor":"University of Texas Southwestern Medical Center","biomarkers":" MUC16","pipe":" | ","alterations":" MUC16 elevation","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MUC16 elevation"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 03/01/2012","start_date":" 03/01/2012","primary_txt":" Primary completion: 03/01/2014","primary_completion_date":" 03/01/2014","study_txt":" Completion: 03/01/2014","study_completion_date":" 03/01/2014","last_update_posted":"2017-07-31"}]